LEAVE BEHINDS
Because what kind of HCP writer would I be without leave behinds?!
Starting & Maintaining Patients on CAMZYOS
Prescribing CAMZYOS can be a challenge for community cardiologists outside of Centers of Excellence. This piece aims to showcase a streamlined approach to initiating treatment and monitoring patients through the CAMZYOS REMS program.
Revealing the Masquerader (unbranded)
Hypertrophic cardiomyopathy is often referred to as “The Great Masquerader” due to nonspecific symptoms that overlap with other conditions. This comprehensive piece outlines suspicion, identification, and management of HCM.
Echocardiography Guidelines
Echocardiography is the primary modality for identifying HCM and its subtypes. This piece summarizes imaging guidelines both cardiologists and sonographers––HCM’s impressive multidisciplinary duo.
Making a Shared Decision About Treatment
CAMZYOS requires patient compliance and understanding. This piece works to champion discussions between patient and provider about the disease, its burden, and how CAMZYOS differs from historical SoC treatments like beta blockers.